Cargando…
Activation of transforming growth factor-β(1 )and early atherosclerosis in systemic lupus erythematosus
The efficiency of activating latent transforming growth factor (TGF)-β(1 )in systemic lupus erythematosus (SLE) may control the balance between inflammation and fibrosis, modulating the disease phenotype. To test this hypothesis we studied the ability to activate TGF-β(1 )in SLE patients and control...
Autores principales: | Jackson, Michelle, Ahmad, Yasmeen, Bruce, Ian N, Coupes, Beatrice, Brenchley, Paul EC |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526639/ https://www.ncbi.nlm.nih.gov/pubmed/16646981 http://dx.doi.org/10.1186/ar1951 |
Ejemplares similares
-
Genetic epidemiology: Systemic lupus erythematosus
por: Ahmad, Yasmeen A, et al.
Publicado: (2001) -
Aortic Atherosclerosis in Systemic Lupus Erythematosus
por: Roldan, Paola C, et al.
Publicado: (2014) -
rhErythropoietin-b as a tissue protective agent in kidney transplantation: a pilot randomized controlled trial
por: Coupes, Beatrice, et al.
Publicado: (2015) -
Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus
por: Gómez-Bernal, Fuensanta, et al.
Publicado: (2023) -
Flares in patients with systemic lupus erythematosus
por: McElhone, Kathleen, et al.
Publicado: (2020)